Results 221 to 230 of about 137,161 (327)
Breakdown of C3 complement and IgG in peritonitis exudate-pathophysiological aspects and therapeutic approach [PDF]
Billing, A. +5 more
core
Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study [PDF]
Dimitrios Chanouzas +16 more
openalex +1 more source
Early bedside removal of the ureteral stent proved feasible and well tolerated, achieving a high level of patient satisfaction. This approach was associated with a reduced incidence of urinary tract infections, without a statistically significant increase in major urological complications. ABSTRACT Background During kidney transplantation, the use of a
François Audenet +9 more
wiley +1 more source
Clinical efficacy of postauricular injection of Methylprednisolone in the treatment of patients with sudden deafness: A retrospective study. [PDF]
Zhu X, Li J, Yang M, Zhang T, She W.
europepmc +1 more source
Methylprednisolone pulse therapy for nonrenal lupus erythematosus. [PDF]
S Eyanson +3 more
openalex +1 more source
This retrospective case series of acyclovir‐resistant HSV infection in pediatric patients undergoing allogeneic HSCT discusses the clinical course, associated complications, and treatment, including side effects. We propose the first algorithm for investigating and managing acyclovir‐resistant HSV infections in pediatric HSCT recipients, highlighting ...
Jenna Nunn +9 more
wiley +1 more source
Pemphigus Vulgaris Successfully Treated with Belimumab: A Case Report.
Zheng L, Si Y, She X, Fang R.
europepmc +1 more source
Fatal Myocarditis Following Adjuvant Immunotherapy: A Case Report and Literature Review. [PDF]
Torounidou N +7 more
europepmc +1 more source
ABSTRACT Introduction Studies evaluating the incidence of infections after belatacept as a substitute for calcineurin inhibitors (CNI) or antimetabolite in kidney transplant (KT) yielded conflicting results. We compared infectious outcomes after belatacept‐use to no belatacept‐use in KT recipients.
Hareesh Singam +5 more
wiley +1 more source

